1. Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?

   • H. J. McKenna

   REVIEW Pages: 281 - 286

2. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer

   • Maurizio Setti
   • Donatella Bignardi
   • Francesco Indiveri

   ORIGINAL PAPER Pages: 287 - 296

3. Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model

   • Kazuki Yamanaka
   • Isao Hara
   • Sadao Kamidono

   ORIGINAL ARTICLE Pages: 297 - 302

4. An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy

   • Pamela M. J. McLaughlin
   • Bart-Jan Kroesen
   • Lou F. M. H. de Leij

   ORIGINAL ARTICLE Pages: 303 - 311

5. ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity

   • Laura L. Worth
   • Shu-Fang Jia
   • Eugenie S. Kleinerman

   ORIGINAL ARTICLE Pages: 312 - 320

6. Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells

   • Peter Jantscheff
   • Richard Herrmann
   • Christoph Rochlitz

   ORIGINAL ARTICLE Pages: 321 - 330

7. The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon α and lymphokine-activated killer cells

   • Wim H. J. Kruit
   • Paul I. M. Schmitz
   • Gerrit Stoter

   ORIGINAL ARTICLE Pages: 331 - 335

8. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4⁺ T cells

   • Steven C. Eck
   • Laurence A. Turka

   SHORT COMMUNICATION Pages: 336 - 341